Nov. 17-20, 2019Integrating multidisciplinary facets of basic cancer immunology and immunotherapy
Long-term Survival Rate for Subset of Patients With Advanced Melanoma Following BRAF- and MEK-targeted Treatment Combination Higher Than Historical Rate
Antibody-Drug Conjugate Shows Early Promise in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
AACR Applauds Nomination of Stephen M. Hahn, MD, as FDA Commissioner
AACR Project GENIE Begins Five-year Collaborative Research Project with $36 Million in New Funding
San Antonio Breast Cancer Symposium, Dec. 10-14, 2019
Advancing Precision Medicine Drug Development, Jan. 9-12, 2020
Sixth AACR-IASLC International Joint Conference: Lung Cancer Translational Science, Jan. 11-14, 2020
William G. Nelson, MD, PhD, Editor-in-Chief of Cancer Today magazine, discusses the merits of value-based programs that reward health care providers for the quality of care they give to patients.
AACR's CEO, Margaret Foti, PhD, MD (hc), praised Stephen Hahn, MD, President Trump's nominee for commissioner of the FDA. According to CNN, she said Hahn is "esteemed for the breadth and depth of his scientific knowledge and expertise." Hahn is a member of the AACR.